Dissecting tumour pathophysiology using intravital microscopy

Nature Reviews Cancer

Volumn 2, Issue 4, 2002, Pages 266-276

  Jain, Rakesh K ^a   Munn, Lance L ^a   Fukumura, Dai ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; GREEN FLUORESCENT PROTEIN; PALLADIUM TETRAKIS(4 CARBOXYPHENYL)PORPHYRIN; PORPHYRIN DERIVATIVE; RHODAMINE; TETRAMETHYLRHODAMINE; UNCLASSIFIED DRUG; PHOTOPROTEIN;

ANIMAL CELL; BLOOD VESSEL WALL; CANCER CHEMOTHERAPY; CELL INTERACTION; CELL KINETICS; CIRCULATION; DIAGNOSTIC APPROACH ROUTE; EXTRACELLULAR MATRIX; FUNCTIONAL ANATOMY; HOST SELECTION; HUMAN; HUMAN CELL; INTRAVITAL MICROSCOPY; LYMPH FLOW; MICROSCOPY; MOLECULAR DYNAMICS; MOLECULAR PROBE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SPACE; TIME; TREATMENT PLANNING; TUMOR MODEL; ANIMAL; CELL CULTURE; CONFOCAL MICROSCOPY; DISEASE MODEL; FLUORESCENCE MICROSCOPY; GUINEA PIG; METABOLISM; METHODOLOGY; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); RABBIT; RAT; ULTRASTRUCTURE;

ANIMALS; DISEASE MODELS, ANIMAL; GREEN FLUORESCENT PROTEINS; GUINEA PIGS; HUMANS; LUMINESCENT PROTEINS; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RABBITS; RATS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0036548794     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc778     Document Type: Review

References (142)

1. Jain, R. K., Schlenger, K., Hockel, M. & Yuan, F. Quantitative angiogenesis assays: progress and problems. Nature Med. 3, 1203-1208 (1997).
2. Jain, R. K., Munn, L. L. & Fukumura, D. in Tumor Models in Cancer Research (ed. Teicher, B. A.) 647-671 (Humana, Totowa, 2001).
3. Brown, E. B. et al. In vivo measurement of gene expression, angiogenesis, and physiological function in tumors using multiphoton laser scanning microscopy. Nature Med. 7, 864-868 (2001). First and comprehensive application of multiphoton laser-scanning microscopy for molecular, cellular, anatomical and functional imaging of tumors in vivo.
4. Padera, T. P., Stoll, B. R., So, P. T. C. & Jain, R. K. High-speed intravital multiphoton laser scanning microscopy of microvasculature, lymphatics, and leukocyte-endothelial interactions. Mol. Imaging 1, 9-15 (2002). High-speed image acquisition by multi-photon laser-scanning microscopy for intravital microscopy.
5. Nugent, L. J. & Jain, R. K. Extravascular diffusion in normal and neoplastic tissues. Cancer Res. 44, 238-244 (1984).
6. Yuan, F. et al. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial window. Cancer Res. 54, 4564-4568 (1994). Establishment of cranial window models. Revealed intra- and inter-tumour heterogeneity of vascular permeability.
7. Jain, R. K. Barriers to drug delivery in solid tumors. Sci. Am. 271, 58-65 (1994).
8. Martin, G. R. & Jain, R. K. Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy. Cancer Res. 54, 5670-5674 (1994).
9. Torres-Filho, I. P., Leunig, M., Yuan, F., Intaglietta, M. & Jain, R. K. Noninvasive measurement of microvascular and interstitial oxygen profiles in a human tumor in SCID mice. Proc. Natl Acad. Sci. USA 91, 2081-2085 (1994).
10. 2 in solid tumours.
11. 2 and pH by distinct pathways.
12. Weissleder, R. Scaling down imaging: molecular mapping of cancer in mice. Nature Rev. Cancer 2, 11-18 (2002).
13. Becker, A. et al. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nature Biotechnol. 19, 327-331 (2001).
14. Zhang, J., Ma, Y., Taylor, S. S. & Tsien, R. Y. Genetically encoded reporters of protein kinase A activity reveal impact of substrate tethering. Proc. Natl Acad. Sci. USA 98, 14997-15002 (2001).
15. Ting, A. Y., Kain, K. H., Klemke, R. L. & Tsien, R. Y. Genetically encoded fluorescent reporters of protein tyrosine kinase activities in living cells. Proc. Natl Acad. Sci. USA 98, 15003-15008 (2001). References 14 and 15 are good examples of recent advances in molecular imaging probes. These are fusion protein reporters in which CFP and YFP are attached to a specific kinase-binding domain. Once the signalling pathway of interest is activated, the reporter fusion protein changes conformation and alters its fluorescence emission owing to fluorescence resonance energy transfer. By using ratio imaging, these probes allow quantitation of cellular level response/signalling.
16. Fukumura, D. et al. Tumor induction of VEGF promoter in stromal cells. Cell 94, 715-725 (1998). First in vivo visualization of gene promoter activity. Revealed VEGF activation in host stromal cells by tumour cells and underscored the importance of host-tumour interactions.
17. Tsuzuki, Y. et al. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia inducible factor-1α hypoxia response element VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res. 60, 6248-6252 (2000).
18. Gohongi, T. et al. Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor-β1. Nature Med. 5, 1203-1208 (1999).
19. Gullino, P. in Cancer (ed. Becker, F.) 327-354 (Plenum, New York, 1975).
20. Fidler, I. Seed and soil revisited: contribution of the organ microenvironment to cancer metastasis. Surg. Oncol. Clin. N. Am. 10, 257-269 (2001).
21. Greer, L. & Szalay, A. Imaging of light emission from the expression of luciferase in living cells and organisms: a review. Luminescence 17, 43-74 (2002).
22. Terskikh, A. et al. 'Fluorescent timer': protein that changes color with time. Science 290, 1585-1588 (2000).
23. Baird, G. S., Zacharias, D. A. & Tsien, P. Y. Biochemistry, mutagenesis, and oligomerization of DsRed, a red fluorescent protein from coral. Proc. Natl Acad. Sci. USA 97, 11984-11989 (2000).
24. Marchant, J. S. et al. Multiphoton-evoked color change of DsRed as an optical highlighter for cellular and subcellular labeling. Nature Biotechnol. 19, 645-649 (2001).
25. Wood, S. Pathogenesis of metastasis formation observed in vivo in the rabbit ear chamber. Arch. Pathol. 66, 550-568 (1958).
26. Zeidman, I. The fate of circulating tumor cells 1. Passage of cells through capillaries. Cancer Res. 21, 38-39 (1961).
27. Chambers, A. F. et al. Steps in tumor metastasis: new concepts from intravital videomicroscopy. Cancer Metastasis Rev. 14, 279-301 (1995).
28. Li, C.-Y. et al. Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models. J. Natl Cancer Inst. 92, 143-147 (2000).
29. Chang, Y. S. et al. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc. Natl Acad. Sci. USA 97, 14608-14613 (2000).
30. Wyckoff, J. B., Jones, J. G., Condeelis, J. S. & Segall, J. E. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res. 60, 2504-2511 (2000).
31. Chishima, T. et al. Cancer invasion and micrometastasis visualized in live tissue by green fluoreseenct protein expression. Cancer Res. 57, 2042-2047 (1997).
32. Naumov, G. N. et al. Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. J. Cell Sci. 112, 1835-1842 (1999). References 27-32 are representative studies using GFP-labelled cells to understand various steps in metastasis.
33. Jain, R. K. & Fenton, B. T. Intra-tumor lymphatic vessels: a case of mistaken identity or malfunction. J. Natl Cancer Instit. 94, 417-421 (2002).
34. Ohkubo, C., Bigos, D. & Jain, R. K. Interleukin 2 induced leukocyte adhesion to the normal and tumor microvascular endothelium in vivo and its inhibition by dextran sulfate: implications for vascular leak syndrome. Cancer Res. 51, 1561-1563 (1991).
35. Wu, N. Z., Klitzman, B., Dodge, R. & Dewhirst, M. W. Diminished leukocyte-endothelium interaction in tumor microvessels. Cancer Res. 52, 4265-4268 (1992).
36. Fukumura, D. et al. Tumor necrosis factor-α-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain. Cancer Res. 55, 4824-4829 (1995). References 34-36 are representative works that show heterogeneous leukocyte-endothelium interactions in tumours.
37. Jain, R. K. et al. Leukocyte-endothelial adhesion and angiogenesis in tumors. Cancer Metastasis Rev. 15, 195-204 (1996).
38. Fukumura, D., Yuan, F., Endo, M. & Jain, R. K. Role of nitric oxide in tumor microcirculation: blood flow, vascular permeability, and leukocyte-endothelial interactions. Am. J. Pathol. 150, 713-725 (1997).
39. Fukumura, D., Yuan, F., Monsky, W. L., Chen, Y. & Jain, R. K. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am. J. Pathol. 151, 679-688 (1997).
40. Jain, R. K., Munn, L. L., Fukumura, D. & Melder, R. J. in Methods in Molecular Medicine Vol. 18: Tissue Engineering Methods and Protocols (eds Morgan, J. R. & Yarmush, M. L.) 553-575 (Humana, Totowa, 1998).
41. Sasaki, A., Melder, R. J., Whiteside, T. L., Herberman, R. B. & Jain, R. K. Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculation. J. Natl Cancer Inst. 83, 433-437 (1991).
42. Melder, R. J., Salehi, H. A. & Jain, R. K. Interaction of activated natural killer cells with normal and tumor vessels in cranial windows in mice. Microvascular Res. 50, 35-44 (1995).
43. Melder R. J. et al. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nature Med. 2, 992-997 (1996).
44. Detmar, M. et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Invest. Dermatol. 111, 1-6 (1998).
45. Jain, R. K. et al. Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. Proc. Natl Acad. Sci. USA 95, 10820-10825 (1998). First demonstration of 'normalization' of tumour vasculature in response to anti-angiogenic treatment.
46. Kadambi, A. et al. Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: role of VEGF-receptor 2 and host VEGF-A. Cancer Res. 61, 2404-2408 (2001).
47. Melder, R. J., Yuan, J., Munn, L. L. & Jain, R. K. Erythrocytes enhance lymphocyte rolling and arrest in vivo. Microvascular Res. 59, 316-322 (2000).
48. Yamada, S., Melder, R. J., Leunig, M., Ohkubo, C. & Jain, R. K. Leukocyte rolling increases with age. Blood 86, 4707-4708 (1995).
49. Yu, J. L. et al. Heterogeneous vascular dependence of tumor cell populations. Am. J. Pathol. 158, 1325-1334 (2001).
50. Groner, W. et al. Orthogonal polarization spectral imaging: a new method for study of the microcirculation. Nature Med. 5, 1209-1213 (1999).
51. Yuan, F. et al. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res. 54, 3352-3356 (1994).
52. Yuan, F. et al. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl Acad. Sci. USA 93, 14765-14770 (1996).
53. Endrich, B., Reinhold, H. S., Gross, J. F. & Intaglietta, M. Tissue perfusion inhomogeneity during early tumor growth in rats. J. Natl Cancer Inst. 62, 387-395 (1979).
54. Endrich, B., Intaglietta, M., Reinhold, H. S. & Gross, J. F. Hemodynamic characteristics in microcirculatory blood channels during early tumor growth. Cancer Res. 39, 17-23 (1979). References 53 and 54 described, for the first time, the use of IVM to measure temporal and spatial heterogeneity in tumour blood flow.
55. Jain, R. K. Determinants of tumor blood flow: a review. Cancer Res. 48, 2641-2658 (1988).
56. Gazit, Y., Berk, D. A., Leunig, M., Baxter, L. T. & Jain, R. K. Scale-invariant behavior and vascular network formation in normal and tumor tissue. Phys. Rev. Lett. 75, 2428-2431 (1995).
57. Baish, J. W. & Jain, R. K. Fractals and cancer. Cancer Res. 60, 3683-3688 (2000).
58. Izumi, Y., Xu, L., diTomaso, E., Fukumura, D. & Jain, R. K. Herceptin acts as an anti-angiogenic cocktail. Nature 416, 279-280 (2002).
59. Leu, A. J., Berk, D. A., Lymboussaki, A., Alitalo, K. & Jain, R. K. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res. 60, 4324-4327 (2000).
60. Padera, T. P., Yun, C-O., Carreira, C. M. & Jain, R. K. Local mechanics and VEGF-C alter pen-tumor lymphatic function. Proc. Am. Assoc. Cancer Res. 41, 88 (2000). References 59 and 60 show the lack of functional lymphatics within tumours and lymphatic hyperplasia in the tumour margin.
61. Jeltsch, M. et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276, 1423-1425 (1997).
62. Hobbs, S. K. et al. Regulation of transport pathways in tumor vessels: role of tumor type and host microenvironment. Proc. Natl. Acad. Sci. USA 95, 4607-4612 (1998). First determination of pore size in tumour vessels and how pore size is affected by host-tumour interactions and the microenvironment.
63. Monsky, W. L. et al. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res. 59, 4129-4135 (1999).
64. Hashizume, H. et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 156, 1363-1380 (2000).
65. Jain, R. K. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J. Controlled Release 74, 7-25 (2001).
66. Leunig, M. et al. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res. 52, 6553-6560 (1992).
67. Carmeliet, P. & Jain, R. K. Angiogenesis in cancer and other diseases: from genes to function to therapy. Nature 407, 249-257 (2000).
68. Gerlowski, L. E. & Jain, R. K. Microvascular permeability of normal and neoplastic tissues. Microvasc. Res. 31, 288-305 (1986).
69. Yuan, F., Leunig, M., Berk, D. A. & Jain, R. K. Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. Microvasc. Res. 45, 269-289 (1993).
70. Lichtenbeld, H. C., Yuan, F., Michel, C. C. & Jain, R. K. Perfusion of single tumor microvessels: application to vascular permeability measurement. Microcirculation 3, 349-357 (1996). References 68-70 describe vascular permeability measurements in tumour vessels and demonstrate the lack of convection.
71. Jain, R. K. & Munn, L. L. Leaky vessels? Call Ang1! Nature Med. 6, 131-132 (2000).
72. Yuan, F. et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cut-off size. Cancer Res. 55, 3752-3756 (1995).
73. Dellian, M., Yuan, F., Trubetskoy, V., Torchilin, V. & Jain, R. K. Vascular permeability in a human tumor xenograft: molecular charge dependence. Br. J. Cancer 82, 1513-1518 (2000).
74. Thurston, G. et al. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J. Clin. Invest. 101, 1401-1413 (1998).
75. Chary, S. R. & Jain, R. K. Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. Proc. Natl Acad. Sci. USA 86, 5385-5389 (1989).
76. Berk, D. A., Yuan, F., Leunig, M. & Jain, R. K. Direct in vivo measurement of targeted binding in a human tumor xenograft. Proc. Natl Acad. Sci. USA 94, 1785-1790 (1997). References 75 and 76 provided the first measurements of convection, diffusion and binding of molecules in vivo.
77. Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J. & Jain, R. K. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res. 60, 2497-2503 (2000).
78. Pluen, A. et al. Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors. Proc. Natl Acad. Sci. USA 98, 4628-4633 (2001).
79. Leu, A. J., Berk, D. A., Yuan, F. & Jain, R. K. Flow velocity in the superficial lymphatic network of the mouse tail. Am. J. Physiol. 267, H1507-H1513 (1994).
80. Berk, D. A., Swartz, M. A., Leu, A. J. & Jain, R. K. Transport in lymphatic capillaries. II. Microscopic velocity measurement with fluorescence photobleaching. Am. J. Physiol. 270, H330-H337 (1996).
81. Swartz, M. A., Berk, D. A. & Jain, R. K. Transport in lymphatic capillaries. I. Macroscopic measurements using residence time distribution theory. Am. J. Physiol. 270, H324-H329 (1996).
82. Lee, C. G. et al. Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res. 60, 5565-5570 (2000).
83. Hansen-Algenstaedt, N. et al. Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy. Cancer Res. 60, 4556-4560 (2000).
84. Jain, R. K. Normalizing tumor vaculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nature Med. 7, 987-989 (2001).
85. Teicher, B. A. et al. Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma. Breast Cancer Res. Treat. 36, 227-236 (1995).
86. Browder, T. et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res. 60, 1878-1886 (2000).
87. Murata, R., Nishimura, Y. & Hiraoka, M. An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 37, 1107-1113 (1997).
88. Ma, J. et al. Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470. Cancer Res. 61, 5491-5498 (2001).
89. Huang, Q. et al. Noninvasive visualization of tumors in rodent dorsal skin window chambers: a novel model for evaluating anti-cancer therapies. Nature Biotechnol. 17, 1033-1035 (1999).
90. Vajkoczy, P., Ullrich, A. & Menger, M. Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation. Neoplasia 2, 53-61 (2000).
91. Hoffman, R. M. Visualization of GFP-expressing tumors and metastasis in vivo. BioTechniques 30, 1016-1026 (2001).
92. Huang, W. H., Aramburu, J., Douglas, P. S. & Izumo, S. Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy. Nature Med. 6, 482-483 (2000).
93. Garcia-Parajo, M. F., Koopman, M., van Dijk, E. M. H. P., Subramaniam, V. & van Hulst, N. F. The nature of fluorescence emission in the red fluorescent protein DsRed, revealed by single-molecule detection. Proc. Natl Acad. Sci. USA 98, 14392-14397 (2001).
94. Cotlet, M. et al. Identification of different emitting species in the red fluorescent protein DsRed by means of ensemble and single-molecule spectroscopy. Proc. Natl Acad. Sci. USA 98, 14398-14403 (2001).
95. Hadjantonakis, A. K. & Nagy, A. The color of mice: in the light of GFP-variant reporters. Histochem. Cell Biol. 115, 49-58 (2001).
96. Mitchell, P. Turning the spotlight on cellular imaging. Nature Biotechnol. 19, 1013-1017 (2001).
97. Roessel, P. V. & Brand, A. H. Imaging into the future: visualizing gene expression and protein interactions with fluorescent proteins. Nature Cell Biol. 4, E15-E20 (2002).
98. Kleinfeld, D., Mitra, P. P., Helmchen, F. & Denk, W. Fluctuations and stimulus-induced changes in blood flow observed in individual capillaries in layers 2 through 4 of rat neocortex. Proc. Natl Acad. Sci. USA 95, 15741-15746 (1998).
99. Lendvai, B., Stern, E. A., Chen, B. & Svoboda, K. Experience-dependent plasticity of dendritic spines in the developing rat barrel cortex in vivo. Nature 404, 876-881 (2000).
100. Huang, D. et al. Optical coherence tomography. Science 254, 1178-1181 (1991).
101. Boppart, S. et al. High resolution optical coherence tomography-guided laser ablation of surgical tissue. J. Surg. Res. 82. 275-284 (1999).
102. Boppart, S. et al. In vivo cellular optical coherence tomography imaging. Nature Med. 4, 861-865 (1998).
103. Beaurepaire, E., Moreaux, L., Amblard, F. & Mertz, J. Combined scanning optical coherence and two-photon excited fluorescence microscopy. Optics Lett. 24. 969 (1999).
104. Delaney, P. M., Harris, M. R. & King, R. G. Novel microscopy using fibre optic confocal imaging and its suitability for subsurface blood vessel imaging in vivo. Clin. Exp. Pharmacol. Physiol. 20, 197-198 (1993).
105. Helmchen, F., Fee, M. S., Tank, D. W. & Denk, W. A miniature head-mounted two-photon microscope: high-resolution brain imaging in freely moving animals. Neuron 31, 903-912 (2001). Development of a miniature two-photon microscope.
106. Shioda, T., Munn, L., Fenner, M., Jain, R. & Isselbacher, K. Early events of metastasis in the microcirculation involve changes in gene expression of cancer cells: tracking mRNA levels of metastasizing cancer cells in the chick embryo chorioallantoic membrane. Am. J. Pathol. 150, 2099-2112 (1997).
107. Jain, R. K. Delivery of molecular and cellular medicine to solid tumors. Microcirculation 4, 1-23 (1997).
108. Ide, A. G., Baker, N. H. & Warren, S. L. Vascularization of the Brown-Pearce rabbit epithelioma transplant as seen in the transparent ear chamber. Am. J. Roentgenol. 42, 891-899 (1939).
109. Dudar, T. E. & Jain, R. K. Differential response of normal and tumor microcirculation to hyperthermie. Cancer Res. 44, 605-612 (1984).
110. Algire, G. H. An adaptation of the transparent chamber technique to the mouse. J. Natl Cancer Inst. 4, 1-11 (1943).
111. Algire, G. H. Microscopic studies of the early growth of a transplantable melanoma of the mouse, using the transparent-chamber technique. J. Natl Cancer Inst. 4, 13-20 (1943).
112. Kligerman, M. M. & Henel, D. K. Some aspects of the microcirculation of a transplantable experimental tumor. Radiology 76, 810-817 (1961).
113. Reinhold, H. S. Improved microcirculation in irradiated tumours. Eur. J. Cancer 7, 273-280 (1971).
114. Falkvoll, K. H., Rofstad, E. K., Brustad, T. & Marton, P. A transparent chamber for the dorsal skin fold of athymic mice. Exp. Cell Biol. 52, 260-268 (1984).
115. Asaishi, K., Endrich, B., Gotz, A. & Messmer, K. Quantitative analysis of microvascular structure and function in the amelanotic melanoma A-Mel-3. Cancer Res. 41, 1898-1904 (1981).
116. Yamura, H., Suzuki, M. & Sato, H. Transparent chamber in the rat skin for studies on microcirculation in cancer tissue. Gann 62, 177-185 (1971).
117. Reinhold, H. S., Blachiwiecz, B. & Blok, A. Oxygenation and reoxygenation in 'Sandwich' tumours. Bibl. Anat. 15, 270-272 (1977).
118. Dewhirst, M. W. et al. Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. Int. J. Radiat. Oncol. Biol. Phys. 17, 91-99 (1989).
119. Lutz, B. R., Fulton, G. P., Patt, D. I. & Handler, A. H. The growth rate of tumor transplants in the cheek pouch of the hamster (Mesocricetus auratus). Cancer Res. 10, 231-232 (1950).
120. Chute, R. N., Sommers, S. C. & Warren, S. Heterotransplantation of human cancer. II. Hamster cheek pouch. Cancer Res. 12, 912-914 (1952).
121. Toolan, H. W. Transplantable human neoplasms maintained in cortisone-treated laboratory animals: H. S. #1; H. Ep. #1; H. Ep. #2; H. Ep. #3; and H. Emb. Rh. #1. Cancer Res. 14, 660-666 (1954).
122. Goodall, C. M., Sanders, A. G. & Shubik, P. Studies of vascular patterns in living tumors with a transparent chamber inserted in hamster cheek pouch. J. Natl Cancer Inst. 35, 497-521 (1965).
123. Eddy, H. A. & Casarett, G. W. Development of the vascular system in the hamster malignant neurilemmoma. Microvasc. Res. 6, 63-82 (1973).
124. Norrby, K., Jakobsson, A. & Sörbo, J. Quantitative angiogenesis in spreads of intact rat mesenteic windows. Microvasc. Res. 39, 341-348 (1990).
125. Yanagi, K. & Ohsima, N. Angiogenic vascular growth in the rat peritoneal disseminated tumor model. Microvasc. Res. 51, 15-28 (1996).
126. Heuser, L. S. & Miller, F. N. Differential macromolecular leakage from the vasculature of tumors. Cancer 57, 461-464 (1986).
127. Monsky, W. L. et al. Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad vs. cranial tumors. Clin. Cancer Res. 1008-1013 (2002).
128. Schmidt, J. et al. Reduced basal and stimulated leukocyte adherence in tumor endothelium of experimental pancreatic cancer. Int. J. Pancreatol. 26, 173-179 (1999).
129. Tsuzuki, Y. et al. Pancreas microenvironment promotes VEGF expression and tumor growth: novel window models for pancreatic tumor angiogenesis and microcirculation. Lab. Invest. 81, 1439-1452 (2001).
130. Funakoshi, N. et al. A new model of lung metastasis for intravital studies. Microvasc. Res. 59, 361-367 (2000).
131. Luckè, B. & Schlumberger, H. The manner of growth of frog carcinoma, studied by direct microscopic examination of living intraocular transplants. J. Exp. Med. 70, 257-268 (1939).
132. Greene, H. S. N. The significance of heterologous transplantability of human cancer. Cancer 5, 24-44 (1952).
133. Gimbrone, M. A. J. & Gullino, P. M. Angiogenic capacity of preneoplastic lesions of the murine mammary gland as a marker of neoplastic transformation. Cancer Res. 36, 2611-2620 (1976).
134. Brem, S. S., Gullino, P. M. & Medina, D. Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia. Science 195, 880-882 (1977).
135. Maiorana, A. & Gullino, P. M. Acquisition of angiogenic capacity and neoplastic transformation in the rat mammary gland. Cancer Res. 38, 4409-4414 (1978).
136. Gimbrone, M. A. J., Cotran, R. S., Leapman, S. B. & Folkman, J. Tumor growth and neovascularization: an experimental model using the rabbit cornea. J. Natl Cancer Inst. 52, 413-427 (1974).
137. Ausprunk, D. H. & Folkman, J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc. Res. 14, 53-65 (1977).
138. Muthukkaruppan, V. R. & Auerbach, R. Angiogenesis in the mouse cornea. Science 205, 1416-1418 (1979).
139. Suit, H. & Shalek, R. Response of anoxic C3H mouse mammary carcinoma isotransplants (I-25mm3) to X-irradiation. J. Natl Cancer Inst. 31, 479-495 (1963).
140. Dellian, M., Witwer, B. P., Salehi, H. A., Yuan, F. & Jain, R. K. Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am. J. Pathol. 149, 59-72 (1996).
141. 2 gradients in window chamber tumours: impact on tumor hypoxia. Br. J. Cancer 79, 1717-1722 (1999).
142. Kimura, H. et al. Fluctuations in red cell flux in tumor microvessels can lead to transient hyoxia and reoxygenation in tumor parenchyma. Cancer Res. 56, 5522-5528 (1996).